Portland, OR, Oct. 07, 2021 (GLOBE NEWSWIRE) -- According to the report published by Portland-based research firm Allied Market Research, the global urinary tract cancer market generated $1.7 billion in 2020 and is projected to reach $8.7 billion by 2030, witnessing a CAGR of 18.6% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Rise in prevalence of urinary tract cancer, surge in geriatric population, and increase in number of bladder cancer research centers drive the growth of the global urinary tract cancer market. However, risk associated with the use of drugs employed in urinary tract cancer restrains the market to some extent. On the other hand, increase in healthcare expenditure worldwide presents new opportunities in the upcoming years.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/612
Impact of COVID-19 on Urinary Tract Cancer Market-
- The outbreak of the COVID-19 pandemic has negatively impacted the global urinary tract cancer market
- Almost all the hospitals and cancer centers have reduced their outpatient capacity and conducting a triage to only select the patients that are in most need of a cystoscopy. This, in turn, caused cancellation and postponements of many non-essential surgical procedures across the world.
Get detailed COVID-19 impact analysis on the Urinary Tract Cancer Market- https://www.alliedmarketresearch.com/request-for-customization/612?reqfor=covid
The report offers detailed segmentation of the global urinary tract cancer market based on cancer type, treatment type, distribution channel, and region.
Based on treatment type, the immunotherapy segment held the highest market share in 2020, holding nearly four-fifths of the total market share, and is expected to continue its leadership status during the forecast period. However, the same segment is estimated to register the highest CAGR of 19.1% from 2021 to 2030.
Based on distribution channel, the retail pharmacy segment held the largest market share in 2020, holding nearly four-fifths of the total market share, and is expected to continue its leadership status during the forecast period. However, the online pharmacy segment is projected to register the highest CAGR of 19.6% from 2021 to 2030.
Based on region, North America contributed to the highest share in terms of revenue in 2020, holding nearly two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, Asia-Pacific is projected to manifest the fastest CAGR of 19.6% during the forecast period.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/612
Leading players of the global urinary tract cancer market analyzed in the research include Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lily and Company, Endo International plc., Exelixis, Inc., GlaxoSmithKline Plc.(GSK), Merck KGAA, Novartis AG, Pfizer Inc., and Johnson & Johnson.
Official Press Release- https://www.alliedmarketresearch.com/press-release/urinary-tract-cancer-market.html
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
